The possible role of vitamin K deficiency in the pathogenesis of Alzheimer’s disease and in augmenting brain damage associated with cardiovascular disease
-
Published:2001-08
Issue:2
Volume:57
Page:151-155
-
ISSN:0306-9877
-
Container-title:Medical Hypotheses
-
language:en
-
Short-container-title:Medical Hypotheses
Reference29 articles.
1. Estimated prevalence of Alzheimer’s disease in the United States;Evans;The Milbank Qtrly,1990
2. Consensus report of the working group on: “Molecular and biochemical markers of Alzheimer’s disease”. Neurobiology of Aging, 1998, 19, 109, 116.
3. Utility of the apolipoprotein-E genotype in the diagnosis of Alzheimer’s disease;Mayeux;New Engl J Med,1998
4. Pharmacologic management of Alzheimer’s disease;Flynn;Ann Pharmacother,1999
5. Knopman, D. S. Advances in methodology and current prospects for primary drug therapies for Alzheimer’s disease. Hooper, N.E. Methods in Molecular Medicine, Vol. 32. Alzheimer’s disease: methods and protocols, Totowa NJ, Humana Press, 2000: 45–60.
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献